Your browser doesn't support javascript.
loading
Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells.
Mout, Lisanne; van Dessel, Lisanne F; Kraan, Jaco; de Jong, Anouk C; Neves, Rui P L; Erkens-Schulze, Sigrun; Beaufort, Corine M; Sieuwerts, Anieta M; van Riet, Job; Woo, Thomas L C; de Wit, Ronald; Sleijfer, Stefan; Hamberg, Paul; Sandberg, Yorick; Te Boekhorst, Peter A W; van de Werken, Harmen J G; Martens, John W M; Stoecklein, Nikolas H; van Weerden, Wytske M; Lolkema, Martijn P.
Afiliación
  • Mout L; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • van Dessel LF; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands; Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands; Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • de Jong AC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Neves RPL; Department of General, Visceral and Pediatric Surgery, Heinrich-Heine University, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Erkens-Schulze S; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Beaufort CM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands; Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • van Riet J; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands; Cancer Computational Biology Center, Erasmus MC Cancer Instit
  • Woo TLC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Hamberg P; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
  • Sandberg Y; Department of Internal Medicine, Maasstad Hospital, Rotterdam, the Netherlands.
  • Te Boekhorst PAW; Department of Hematology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • van de Werken HJG; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands; Cancer Computational Biology Center, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands; Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Stoecklein NH; Department of General, Visceral and Pediatric Surgery, Heinrich-Heine University, University Hospital Düsseldorf, Düsseldorf, Germany.
  • van Weerden WM; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: m.lolkema@erasmusmc.nl.
Eur J Cancer ; 150: 179-189, 2021 06.
Article en En | MEDLINE | ID: mdl-33932725
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Separación Celular / Leucaféresis / Células Neoplásicas Circulantes Tipo de estudio: Observational_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Separación Celular / Leucaféresis / Células Neoplásicas Circulantes Tipo de estudio: Observational_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article